Trials / Withdrawn
WithdrawnNCT05853731
The Effect of Light Therapy on Post-Surgical Pain
The Feasibility of Using Green Light Phototherapy for the Management of Acute Postoperative Pain
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Researchers aim to demonstrate that the use of phototherapy is feasible and may reduce acute postoperative pain based on recent literature. The primary objective is to demonstrate that displaying light-emitting diodes \[LED\] can be achieved in the ICU setting in after cardiac surgery.
Detailed description
The primary aim of this study to determine whether or not green light phototherapy is feasible after cardiac surgery. Patients that will be undergoing heart surgery will be recruited to the study. After surgery they will be exposed to either green or white LEDs for up to 5 hours per day and up to one week after surgery. After their exposure to light therapy, a survey will be given to the patient which will ask questions regarding tolerance of the therapy. A survey will also be given to the staff which will query whether or not the therapy was an impediment to workflow. In addition, the medical record will be reviewed to assess opiate usage in each group as an exploratory aim which may suggest differences in pain experiences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Green light emitting diode | Green light therapy via light emitting diode (LED) in the 520 nanometers (nm) range at 4 lux intensity for up to 5 hours per day, as tolerated. |
| DEVICE | White light emitting diode | Filtered white light via light emitting diode (LED) displayed for up to 5 hours per day, as tolerated |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2023-05-11
- Last updated
- 2024-05-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05853731. Inclusion in this directory is not an endorsement.